Literature DB >> 8842725

The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals.

D E Eberhart1, H E Malter, Y Feng, S T Warren.   

Abstract

Fragile X syndrome is a frequent cause of mental retardation resulting from the absence of FMRP, the protein encoded by the FMR1 gene. FMRP is an RNA-binding protein of unknown function which is associated with ribosomes. To gain insight into FMRP function, we performed immunolocalization analysis of FMRP truncation and fusion constructs which revealed a nuclear localization signal (NLS) in the amino terminus of FMRP as well as a nuclear export signal (NES) encoded by exon 14. A 17 amino acid peptide containing the FMRP NES, which closely resembles the NES motifs recently described for HIV-1 Rev and PKI, is sufficient to direct nuclear export of a microinjected protein conjugate. Sucrose gradient analysis shows that FMRP ribosome association is RNA-dependent and FMRP is found in ribonucleoprotein (RNP) particles following EDTA treatment. These data are consistent with nascent FMRP entering the nucleus to assemble into mRNP particles prior to export back into the cytoplasm and suggests that fragile X syndrome may result from altered translation of transcripts which normally bind to FMRP.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8842725     DOI: 10.1093/hmg/5.8.1083

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  127 in total

Review 1.  Candidate RNA-binding proteins regulating extrasomatic mRNA targeting and translation in mammalian neurons.

Authors:  Stefan Kindler; Michaela Monshausen
Journal:  Mol Neurobiol       Date:  2002-04       Impact factor: 5.590

Review 2.  Genetic effects on human cognition: lessons from the study of mental retardation syndromes.

Authors:  P Nokelainen; J Flint
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-03       Impact factor: 10.154

Review 3.  Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments.

Authors:  Jeremy Veenstra-VanderWeele; Randy D Blakely
Journal:  Neuropsychopharmacology       Date:  2011-09-21       Impact factor: 7.853

4.  The RNA binding domain of Jerky consists of tandemly arranged helix-turn-helix/homeodomain-like motifs and binds specific sets of mRNAs.

Authors:  Wencheng Liu; Jeremy Seto; Etienne Sibille; Miklos Toth
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

5.  Subcellular localization of fragile X mental retardation protein with the I304N mutation in the RNA-binding domain in cultured hippocampal neurons.

Authors:  M Castrén; A Haapasalo; B A Oostra; E Castrén
Journal:  Cell Mol Neurobiol       Date:  2001-02       Impact factor: 5.046

6.  Translational regulation of NeuroD1 expression by FMRP: involvement in glutamatergic neuronal differentiation of cultured rat primary neural progenitor cells.

Authors:  Se Jin Jeon; Ji-Woon Kim; Ki Chan Kim; So Min Han; Hyo Sang Go; Jung Eun Seo; Chang Soon Choi; Jong Hoon Ryu; Chan Young Shin; Mi-Ryoung Song
Journal:  Cell Mol Neurobiol       Date:  2013-12-12       Impact factor: 5.046

Review 7.  RNA transport and local control of translation.

Authors:  Stefan Kindler; Huidong Wang; Dietmar Richter; Henri Tiedge
Journal:  Annu Rev Cell Dev Biol       Date:  2005       Impact factor: 13.827

8.  Effect of in vitro promoter methylation and CGG repeat expansion on FMR-1 expression.

Authors:  G Sandberg; M Schalling
Journal:  Nucleic Acids Res       Date:  1997-07-15       Impact factor: 16.971

Review 9.  FMR1: a gene with three faces.

Authors:  Ben A Oostra; Rob Willemsen
Journal:  Biochim Biophys Acta       Date:  2009-02-21

10.  A study of the ultrastructure of fragile-X-related proteins.

Authors:  Ljiljana Sjekloća; Petr V Konarev; John Eccleston; Ian A Taylor; Dmitri I Svergun; Annalisa Pastore
Journal:  Biochem J       Date:  2009-04-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.